Shanxi Xiyue Pharmaceutical Co., Ltd.

Production of APIs (acetylglutamine, glycine, aluminum glycolate, diclofenac sodium, antipyrine, nitrendipine, phenylalanine, lysine hydrochloride, vitamin E, hydroxymethylnicotinamide, nifedipine, lysine aspirin, clofibrate, acetohydroxyamine), capsules (including penicillins), granules (including penicillins), tablets, pharmaceutical intermediates (license valid until December 31, 2020) and medical devices, sales of self-produced products; new drug research and development, technology transfer and services. Self-operated and agency import and export of goods and technologies, except for goods and technologies that are restricted or prohibited from import and export by the state. (Projects that must be approved according to law can only be carried out after approval by relevant departments)